NCT02653105Active, not recruiting
Women at Risk of Breast Cancer and OLFM4
Evaluation of the Circulating Concentration of Olfactomédine 4 (OLFM4) in Women With a BRCA1 or 2 Gene Mutation or at High Risk of Developing Breast Cancer, According to the Imaging
Source: ClinicalTrials.gov · Last updated 15 Aug 2025
Brief summary (registry, in English)
Does the olfactomédine provide an help to limit the number of false positives in the overall imaging balance and limit the number of unnecessary biopsies?
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 150 (actual)
- First submitted
- 8 Jan 2016
- Start date
- 8 Mar 2016
- Primary completion date
- Mar 2026
- Lead sponsor
- Institut Cancerologie de l'Ouest
- Diseases
- Ovarian cancer
- NCT number
- NCT02653105
What you commit to
- Study type: Interventional
- Participants enrolled: 150
- From 8 Mar 2016 to the primary completion date, Mar 2026
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Women with a history of breast cancer or in situ
Other
- Person who is not affiliated to a social security scheme or beneficiary of such a regime
Who the study is looking for
- Age \> or = 18 years
- High risk women of breast cancer occurrence defined by the following criteria:
- Women carrying a genetic mutation BRCA1 or 2 or TP53, entering or already in screening breast IRM
- Women with a high probability of hereditary predisposition to breast cancer (20% risk at 70 years of breast cancer by BOADICEA model), assessed by the onco-geneticists
- Information of the person and signing the informed consent
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut de Cancerologie de L'Ouest Coordinator of this site? Confirm its status | Angers | France | Unknown status |
| CHU Morvan Coordinator of this site? Confirm its status | Brest | France | Unknown status |
| Instit de Cancérologie de l'Ouest Coordinator of this site? Confirm its status | Nantes | France | Unknown status |
| CHBA Hopital Chubert Coordinator of this site? Confirm its status | Vannes | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.